Silva, S., Duarte, J., Simão, C., & Felizardo, M. (2025). Osimertinib: A Game-Changer in Stage IV EGFR-Driven Lung Cancer.
Chicago Style CitationSilva, Sofia, Joana Duarte, Carla Simão, and Margarida Felizardo. Osimertinib: A Game-Changer in Stage IV EGFR-Driven Lung Cancer. 2025.
MLA CitationSilva, Sofia, Joana Duarte, Carla Simão, and Margarida Felizardo. Osimertinib: A Game-Changer in Stage IV EGFR-Driven Lung Cancer. 2025.
Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero
, which allows the automatic upload of Oasisbr references.